Frankfurt , Dec 20, 2014 – German drugmaker Bayer said on Wednesday it had entered into a definitive agreement to sell veterinary products to treat horses to Sanofi’s animal health unit Merial.
The deal to sell these products – Legend/Hyonate and Marquis – is expected to close in the first quarter, subject to merger control clearance, it said, without providing financial details.
“These equine products have no strategic relevance for our business and represent less than 2 percent of our worldwide sales,” said Dirk Ehle, head of Bayer HealthCare’s Animal Health Division. Reuters
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…